AHA2020: No Benefit for Omega-3 in STRENGTH Trial

A daily dose of a novel omega-3 carboxylic acid (EPA+DHA) compound did not reduce the risk of heart attacks, stroke, revascularization (stenting or bypass surgery), hospitalization for unstable angina, or cardiovascular (CV)...

Read More

Is There Life After Medicine?

M y group of nephrologists is trying to convince our 75-year-old colleague to retire from full-time clinical practice. I think he truly believes that the day he retires, his essence will be forcibly removed from his body, and he...

Read More

For latest news and updates
Email-id is invalid